Cargando…
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients
MicroRNAs (miRNAs) are small non-coding RNA molecules acting as post-transcriptional regulators of gene expression. They are involved in many biological processes, and their dysregulation is implicated in various diseases, including multiple sclerosis (MS). Interferon-beta (IFN-beta) is widely used...
Autores principales: | Hecker, Michael, Thamilarasan, Madhan, Koczan, Dirk, Schröder, Ina, Flechtner, Kristin, Freiesleben, Sherry, Füllen, Georg, Thiesen, Hans-Jürgen, Zettl, Uwe Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759901/ https://www.ncbi.nlm.nih.gov/pubmed/23921681 http://dx.doi.org/10.3390/ijms140816087 |
Ejemplares similares
-
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients
por: Thamilarasan, Madhan, et al.
Publicado: (2013) -
Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis
por: Friess, Jörg, et al.
Publicado: (2017) -
Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms
por: Freiesleben, Sherry, et al.
Publicado: (2016) -
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance
por: Hundeshagen, Alexander, et al.
Publicado: (2012) -
A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene
por: Hecker, Michael, et al.
Publicado: (2019)